$7.78 Billion is the total value of Orbimed Advisors's 159 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 25.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SWTX | SPRINGWORKS THERAPEUTICS INC | $373,634,000 | -2.3% | 6,028,307 | 0.0% | 4.80% | +14.3% | |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $270,587,000 | +1.3% | 4,339,800 | -3.9% | 3.48% | +18.5% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $269,406,000 | -5.8% | 2,500,055 | -4.2% | 3.46% | +10.2% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $235,862,000 | -6.8% | 5,552,300 | -4.8% | 3.03% | +9.0% |
New | THESEUS PHARMACEUTICALS INC | $213,514,000 | – | 16,838,668 | +100.0% | 2.74% | – | |
EWTX | EDGEWISE THERAPEUTICS INC | $213,075,000 | -8.0% | 13,944,680 | 0.0% | 2.74% | +7.7% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $209,239,000 | -13.9% | 1,426,400 | +3.9% | 2.69% | +0.7% |
PMVP | PMV PHARMACEUTICALS INC | $169,333,000 | -22.5% | 7,330,423 | 0.0% | 2.18% | -9.3% | |
PFE | New | PFIZER INC | $154,439,000 | – | 2,615,400 | +100.0% | 1.98% | – |
PRELUDE THERAPEUTICS INCnonvoting | $148,660,000 | -41.9% | 11,895,652 | 0.0% | 1.91% | -32.1% | ||
HUM | Sell | HUMANA INC | $147,647,000 | +13.3% | 318,300 | -5.0% | 1.90% | +32.4% |
ABBV | Sell | ABBVIE INC | $144,716,000 | -5.6% | 1,068,800 | -24.8% | 1.86% | +10.5% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $144,519,000 | -9.2% | 658,100 | -25.0% | 1.86% | +6.2% |
EW | Sell | EDWARDS LIFESCIENCES CORP | $139,422,000 | +9.3% | 1,076,200 | -4.5% | 1.79% | +27.9% |
MRK | Sell | MERCK & CO INC | $136,366,000 | -51.4% | 1,779,300 | -52.3% | 1.75% | -43.1% |
UNH | Sell | UNITEDHEALTH GROUP INC | $136,080,000 | -10.6% | 271,000 | -30.5% | 1.75% | +4.5% |
ISRG | Buy | INTUITIVE SURGICAL INC | $134,306,000 | -3.2% | 373,800 | +167.8% | 1.73% | +13.2% |
NTRA | Sell | NATERA INC | $132,052,000 | -24.7% | 1,413,985 | -10.1% | 1.70% | -11.8% |
ACET | Buy | ADICET BIO INC | $130,250,000 | +129.7% | 7,447,141 | +3.0% | 1.67% | +168.7% |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $125,972,000 | -13.2% | 6,073,850 | 0.0% | 1.62% | +1.5% | |
PRLD | PRELUDE THERAPEUTICS INC | $124,994,000 | -60.2% | 10,039,691 | 0.0% | 1.61% | -53.4% | |
SYK | Buy | STRYKER CORPORATION | $124,431,000 | +39.8% | 465,300 | +37.9% | 1.60% | +63.6% |
GH | GUARDANT HEALTH INC | $122,765,000 | -20.0% | 1,227,400 | 0.0% | 1.58% | -6.4% | |
IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $120,987,000 | -26.2% | 6,337,700 | -4.6% | 1.56% | -13.7% |
XBI | Sell | SPDR SER TRs&p biotech | $113,046,000 | -15.6% | 1,009,700 | -5.3% | 1.45% | -1.3% |
SGEN | Buy | SEAGEN INC | $101,356,000 | +122.7% | 655,600 | +144.6% | 1.30% | +160.6% |
TPTX | Sell | TURNING POINT THERAPEUTICS I | $100,478,000 | -35.9% | 2,106,450 | -10.8% | 1.29% | -25.1% |
HCA | Buy | HCA HEALTHCARE INC | $100,070,000 | +112.7% | 389,500 | +101.0% | 1.29% | +148.9% |
TCDA | Buy | TRICIDA INC | $98,286,000 | +120.3% | 10,280,947 | +6.9% | 1.26% | +158.0% |
KROS | KEROS THERAPEUTICS INC | $98,263,000 | +47.9% | 1,679,417 | 0.0% | 1.26% | +73.0% | |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $90,823,000 | +44.0% | 3,196,876 | +6.7% | 1.17% | +68.5% |
MGTX | Sell | MEIRAGTX HLDGS PLC | $88,490,000 | +63.6% | 3,727,466 | -9.2% | 1.14% | +91.6% |
DXCM | Sell | DEXCOM INC | $82,100,000 | -34.2% | 152,900 | -32.9% | 1.06% | -23.0% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $79,371,000 | -30.6% | 931,915 | -21.8% | 1.02% | -18.8% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $76,059,000 | +787.4% | 860,880 | +676.3% | 0.98% | +940.4% |
SVA | SINOVAC BIOTECH LTD | $72,700,000 | -7.3% | 2,839,500 | 0.0% | 0.94% | +8.5% | |
ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $71,689,000 | -25.9% | 564,300 | -14.6% | 0.92% | -13.3% |
RPTX | REPARE THERAPEUTICS INC | $70,071,000 | -19.6% | 3,322,488 | 0.0% | 0.90% | -5.9% | |
CMPX | New | COMPASS THERAPEUTICS INC | $68,608,000 | – | 21,642,975 | +100.0% | 0.88% | – |
KNTE | KINNATE BIOPHARMA INC | $68,185,000 | -23.0% | 3,847,929 | 0.0% | 0.88% | -9.9% | |
TBPH | Buy | THERAVANCE BIOPHARMA INC | $66,019,000 | +51.3% | 5,974,535 | +1.3% | 0.85% | +77.2% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $63,188,000 | +0.3% | 94,700 | -14.1% | 0.81% | +17.2% |
ABCL | ABCELLERA BIOLOGICS INC | $59,785,000 | -28.6% | 4,180,768 | 0.0% | 0.77% | -16.5% | |
SBTX | SILVERBACK THERAPEUTICS INC | $58,214,000 | -33.3% | 8,740,887 | 0.0% | 0.75% | -22.0% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $56,530,000 | +29.8% | 4,081,592 | 0.0% | 0.73% | +51.8% | |
JANX | Sell | JANUX THERAPEUTICS INC | $55,962,000 | -25.4% | 2,836,386 | -18.2% | 0.72% | -12.7% |
BIIB | Sell | BIOGEN INC | $55,230,000 | -16.7% | 230,200 | -1.7% | 0.71% | -2.5% |
SIBN | Buy | SI-BONE INC | $51,201,000 | +6.3% | 2,305,300 | +2.5% | 0.66% | +24.4% |
ETNB | 89BIO INC | $48,744,000 | -33.3% | 3,729,442 | 0.0% | 0.63% | -21.9% | |
GRCL | GRACELL BIOTECHNOLOGIES INCsponsored ads | $47,625,000 | -56.5% | 7,884,870 | 0.0% | 0.61% | -49.1% | |
PASG | PASSAGE BIO INC | $44,214,000 | -36.2% | 6,962,899 | 0.0% | 0.57% | -25.5% | |
SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $43,371,000 | +1090.9% | 1,981,300 | +939.5% | 0.56% | +1295.0% |
OSH | Sell | OAK STR HEALTH INC | $42,761,000 | -24.3% | 1,290,300 | -2.9% | 0.55% | -11.4% |
XTNT | XTANT MED HLDGS INC | $40,809,000 | -49.6% | 72,873,494 | 0.0% | 0.52% | -40.9% | |
NPCE | NEUROPACE INC | $40,444,000 | -36.4% | 4,012,281 | 0.0% | 0.52% | -25.6% | |
GLPG | Sell | GALAPAGOS NVspon adr | $39,542,000 | +3.9% | 717,257 | -0.9% | 0.51% | +21.5% |
TELA | TELA BIO INC | $38,753,000 | -6.3% | 3,027,542 | 0.0% | 0.50% | +9.7% | |
VRNA | VERONA PHARMA PLCsponsored ads | $38,269,000 | +22.6% | 5,694,841 | 0.0% | 0.49% | +43.4% | |
IKNA | IKENA ONCOLOGY INC | $36,792,000 | -0.6% | 2,933,941 | 0.0% | 0.47% | +16.2% | |
SEM | Sell | SELECT MED HLDGS CORP | $36,268,000 | -21.1% | 1,233,600 | -3.0% | 0.47% | -7.7% |
Sell | ADAGIO THERAPEUTICS INC | $36,180,000 | -84.1% | 4,983,500 | -7.4% | 0.46% | -81.4% | |
ORIC | ORIC PHARMACEUTICALS INC | $34,362,000 | -29.7% | 2,337,574 | 0.0% | 0.44% | -17.7% | |
NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $34,084,000 | +27.7% | 807,100 | +45.2% | 0.44% | +49.5% |
GHRS | Buy | GH RESEARCH PLCordinary shares | $33,332,000 | +5.8% | 1,428,732 | +0.0% | 0.43% | +24.0% |
SRRA | SIERRA ONCOLOGY INC | $32,117,000 | -0.8% | 1,477,320 | 0.0% | 0.41% | +16.0% | |
CYTEK BIOSCIENCES INC | $31,386,000 | -23.8% | 1,923,139 | 0.0% | 0.40% | -10.8% | ||
IMGN | Sell | IMMUNOGEN INC | $28,706,000 | -66.0% | 3,868,786 | -74.0% | 0.37% | -60.2% |
MREO | New | MEREO BIOPHARMA GROUP PLCads | $27,624,000 | – | 17,264,764 | +100.0% | 0.36% | – |
TERN | TERNS PHARMACEUTICALS INC | $26,804,000 | -32.1% | 3,791,204 | 0.0% | 0.34% | -20.5% | |
PCVX | Buy | VAXCYTE INC | $26,090,000 | -0.6% | 1,096,700 | +6.0% | 0.34% | +16.3% |
EVH | Buy | EVOLENT HEALTH INCcl a | $25,954,000 | +142.7% | 938,000 | +171.9% | 0.33% | +183.1% |
Sell | ERASCA INC | $25,983,000 | -43.5% | 1,667,693 | -23.1% | 0.33% | -33.9% | |
VECT | Buy | VECTIVBIO HLDG AG | $25,649,000 | -35.2% | 5,223,804 | +2.0% | 0.33% | -24.1% |
New | VENTYX BIOSCIENCES INC | $25,605,000 | – | 1,289,280 | +100.0% | 0.33% | – | |
VTGN | VISTAGEN THERAPEUTICS INC | $25,173,000 | -28.8% | 12,909,283 | 0.0% | 0.32% | -16.7% | |
THC | Sell | TENET HEALTHCARE CORP | $24,425,000 | +17.9% | 299,000 | -4.1% | 0.31% | +37.7% |
OMIC | Buy | SINGULAR GENOMICS SYSTEMS IN | $24,326,000 | +8.8% | 2,104,359 | +5.3% | 0.31% | +27.2% |
SCPH | SCPHARMACEUTICALS INC | $24,082,000 | -24.5% | 4,797,148 | 0.0% | 0.31% | -11.7% | |
JNCE | Buy | JOUNCE THERAPEUTICS INC | $23,880,000 | +21.0% | 2,859,900 | +7.7% | 0.31% | +41.5% |
KDNY | Sell | CHINOOK THERAPEUTICS INC | $23,132,000 | +27.6% | 1,418,300 | -0.2% | 0.30% | +49.2% |
DBTX | DECIBEL THERAPEUTICS INC | $22,995,000 | -39.7% | 4,945,192 | 0.0% | 0.30% | -29.4% | |
HARP | Buy | HARPOON THERAPEUTICS INC | $21,921,000 | +6.3% | 2,903,508 | +11.2% | 0.28% | +24.2% |
GILD | GILEAD SCIENCES INC | $20,883,000 | +4.0% | 287,600 | 0.0% | 0.27% | +21.3% | |
APLT | Buy | APPLIED THERAPEUTICS INC | $20,707,000 | -44.7% | 2,313,681 | +2.5% | 0.27% | -35.4% |
XENE | Buy | XENON PHARMACEUTICALS INC | $19,712,000 | +170.4% | 631,000 | +32.3% | 0.25% | +216.2% |
LOGC | LOGICBIO THERAPEUTICS INC | $19,558,000 | -49.6% | 8,466,783 | 0.0% | 0.25% | -41.1% | |
GRPH | Buy | GRAPHITE BIO INC | $19,463,000 | -18.1% | 1,565,812 | +8.0% | 0.25% | -4.2% |
MRSN | MERSANA THERAPEUTICS INC | $17,969,000 | -34.0% | 2,888,847 | 0.0% | 0.23% | -22.7% | |
CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $17,789,000 | -37.7% | 2,578,174 | 0.0% | 0.23% | -27.1% | |
DHRPRB | New | DANAHER CORPORATION5% conv pfd b | $17,382,000 | – | 10,000 | +100.0% | 0.22% | – |
CRIS | Buy | CURIS INC | $17,302,000 | -37.3% | 3,634,800 | +3.2% | 0.22% | -26.7% |
ILMN | New | ILLUMINA INC | $17,158,000 | – | 45,100 | +100.0% | 0.22% | – |
MIST | MILESTONE PHARMACEUTICALS IN | $16,924,000 | +14.7% | 2,583,821 | 0.0% | 0.22% | +34.6% | |
GMTX | GEMINI THERAPEUTICS INC | $16,954,000 | -28.0% | 5,826,224 | 0.0% | 0.22% | -15.8% | |
CRVS | CORVUS PHARMACEUTICALS INC | $16,734,000 | -50.2% | 6,943,654 | 0.0% | 0.22% | -41.7% | |
NXTC | NEXTCURE INC | $16,266,000 | -11.0% | 2,711,013 | 0.0% | 0.21% | +4.0% | |
CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $15,692,000 | -29.8% | 406,100 | -2.0% | 0.20% | -17.9% |
Buy | RXSIGHT INC | $15,564,000 | -1.7% | 1,383,500 | +10.7% | 0.20% | +14.9% | |
FLDM | Sell | FLUIDIGM CORP DEL | $14,972,000 | -50.6% | 3,819,348 | -17.0% | 0.19% | -42.3% |
SYBX | SYNLOGIC INC | $14,593,000 | -20.7% | 6,029,995 | 0.0% | 0.19% | -6.9% | |
ACRS | Buy | ACLARIS THERAPEUTICS INC | $14,335,000 | +22.2% | 985,900 | +51.3% | 0.18% | +42.6% |
AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $14,042,000 | -56.0% | 2,956,124 | -26.4% | 0.18% | -48.4% |
CTMX | Buy | CYTOMX THERAPEUTICS INC | $13,919,000 | +50.1% | 3,214,509 | +76.4% | 0.18% | +75.5% |
LUNG | PULMONX CORP | $13,950,000 | -10.9% | 435,000 | 0.0% | 0.18% | +4.1% | |
BNR | Sell | BURNING ROCK BIOTECH LTDsponsored ads | $13,841,000 | -58.3% | 1,452,402 | -21.8% | 0.18% | -51.2% |
FUSN | FUSION PHARMACEUTICALS INC | $13,447,000 | -47.3% | 3,224,770 | 0.0% | 0.17% | -38.4% | |
AMGN | AMGEN INC | $12,846,000 | +5.8% | 57,100 | 0.0% | 0.16% | +24.1% | |
CLXPF | Sell | CYBIN INC | $12,481,000 | -57.6% | 10,524,300 | -21.7% | 0.16% | -50.6% |
CGEM | Sell | CULLINAN ONCOLOGY INC | $12,422,000 | -52.0% | 805,041 | -29.8% | 0.16% | -43.7% |
GLTO | GALECTO INC | $12,396,000 | -15.6% | 4,090,937 | 0.0% | 0.16% | -1.2% | |
QURE | UNIQURE NV | $12,145,000 | -35.2% | 585,574 | 0.0% | 0.16% | -24.3% | |
BLU | Sell | BELLUS HEALTH INC NEW | $11,698,000 | -21.8% | 1,454,800 | -40.7% | 0.15% | -8.5% |
New | SONENDO INC | $11,337,000 | – | 1,968,180 | +100.0% | 0.15% | – | |
NMTR | Buy | 9 METERS BIOPHARMA INC | $10,057,000 | -9.7% | 10,275,887 | +20.0% | 0.13% | +5.7% |
MGTA | Buy | MAGENTA THERAPEUTICS INC | $9,972,000 | -27.6% | 2,250,953 | +18.9% | 0.13% | -15.2% |
RXDX | PROMETHEUS BIOSCIENCES INC | $9,885,000 | +66.8% | 250,000 | 0.0% | 0.13% | +95.4% | |
IMRA | IMARA INC | $9,870,000 | -44.9% | 4,386,568 | 0.0% | 0.13% | -35.5% | |
VOR | VOR BIOPHARMA INC | $9,683,000 | -25.9% | 833,333 | 0.0% | 0.12% | -13.9% | |
AFIB | ACUTUS MED INC | $9,031,000 | -61.4% | 2,648,386 | 0.0% | 0.12% | -54.9% | |
CVRX | Sell | CVRX INC | $8,843,000 | -33.2% | 723,055 | -9.6% | 0.11% | -21.4% |
ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $7,940,000 | -35.7% | 1,584,845 | 0.0% | 0.10% | -25.0% | |
RAPT | New | RAPT THERAPEUTICS INC | $7,970,000 | – | 217,000 | +100.0% | 0.10% | – |
GOSS | New | GOSSAMER BIO INC | $7,725,000 | – | 683,000 | +100.0% | 0.10% | – |
GRAY | GRAYBUG VISION INC | $7,619,000 | -44.9% | 4,163,347 | 0.0% | 0.10% | -35.5% | |
OCX | Buy | ONCOCYTE CORP | $7,582,000 | -25.4% | 3,493,800 | +22.3% | 0.10% | -13.4% |
NAUT | NAUTILUS BIOTECHNOLOGY INC | $7,525,000 | -15.6% | 1,452,774 | 0.0% | 0.10% | -1.0% | |
NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $7,172,000 | -8.7% | 6,000,000 | 0.0% | 0.09% | +7.0% | ||
AVTE | AEROVATE THERAPEUTICS INC | $6,316,000 | -43.8% | 535,714 | 0.0% | 0.08% | -34.7% | |
NTLA | INTELLIA THERAPEUTICS INC | $6,290,000 | -11.9% | 53,200 | 0.0% | 0.08% | +3.8% | |
SYRS | SYROS PHARMACEUTICALS INC | $5,990,000 | -27.1% | 1,837,500 | 0.0% | 0.08% | -14.4% | |
TARA | Buy | PROTARA THERAPEUTICS INC | $5,607,000 | +80.1% | 830,641 | +84.6% | 0.07% | +111.8% |
NRIX | Sell | NURIX THERAPEUTICS INC | $5,340,000 | -69.2% | 184,468 | -68.1% | 0.07% | -63.7% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $5,286,000 | -11.6% | 58,700 | -9.3% | 0.07% | +3.0% |
IMAB | I MABsponsored ads | $5,266,000 | -34.6% | 111,120 | 0.0% | 0.07% | -23.6% | |
HSAQ | HEALTH SCIENCES ACQ CORP 2 | $5,040,000 | +1.9% | 500,000 | 0.0% | 0.06% | +20.4% | |
IPSC | Sell | CENTURY THERAPEUTICS INC | $4,870,000 | -52.4% | 307,047 | -24.6% | 0.06% | -44.2% |
PHGE | BIOMX INC | $4,502,000 | -47.7% | 2,813,489 | 0.0% | 0.06% | -38.9% | |
ALXO | Buy | ALX ONCOLOGY HLDGS INC | $4,461,000 | -59.7% | 207,600 | +38.4% | 0.06% | -53.3% |
IFRX | Sell | INFLARX NV | $4,166,000 | +51.2% | 875,297 | -17.7% | 0.05% | +80.0% |
TALS | TALARIS THERAPEUTICS INC | $3,780,000 | +12.7% | 247,240 | 0.0% | 0.05% | +32.4% | |
FIELD TRIP HEALTH LTD | $3,722,000 | -46.8% | 1,538,470 | 0.0% | 0.05% | -37.7% | ||
INZY | Buy | INOZYME PHARMA INC | $3,591,000 | +5.4% | 526,600 | +79.1% | 0.05% | +24.3% |
SIGHT SCIENCES INC | $3,514,000 | -22.6% | 200,000 | 0.0% | 0.04% | -10.0% | ||
Sell | AADI BIOSCIENCE INC | $3,082,000 | -69.7% | 127,600 | -63.1% | 0.04% | -64.3% | |
XFOR | X4 PHARMACEUTICALS INC | $3,146,000 | -56.7% | 1,373,849 | 0.0% | 0.04% | -50.0% | |
New | EXSCIENTIA PLCads | $2,470,000 | – | 125,000 | +100.0% | 0.03% | – | |
SURF | Sell | SURFACE ONCOLOGY INC | $2,237,000 | -67.5% | 467,945 | -48.6% | 0.03% | -61.8% |
ASLN | ASLAN PHARMACEUTICALS LTDads | $2,206,000 | -37.1% | 1,970,000 | 0.0% | 0.03% | -28.2% | |
New | BRIGHT MINDS BIOSCIENCES INC | $2,131,000 | – | 660,600 | +100.0% | 0.03% | – | |
ADAG | Sell | ADAGENE INCads | $2,123,000 | -46.3% | 263,176 | -4.3% | 0.03% | -37.2% |
APTX | Buy | APTINYX INC | $2,001,000 | +457.4% | 749,500 | +389.0% | 0.03% | +550.0% |
CBIO | Sell | CATALYST BIOSCIENCES INC | $1,581,000 | -85.8% | 1,729,402 | -36.2% | 0.02% | -83.6% |
New | PYXIS ONCOLOGY INC | $1,576,000 | – | 143,640 | +100.0% | 0.02% | – | |
LABP | LANDOS BIOPHARMA INC | $1,359,000 | -67.1% | 283,217 | 0.0% | 0.02% | -62.2% | |
CABA | CABALETTA BIO INC | $1,147,000 | -68.8% | 302,509 | 0.0% | 0.02% | -62.5% | |
LBPH | LONGBOARD PHARMACEUTICALS IN | $554,000 | -44.8% | 113,500 | 0.0% | 0.01% | -36.4% | |
AUGX | New | AUGMEDIX INC | $278,000 | – | 88,363 | +100.0% | 0.00% | – |
New | OWLET INC*w exp 09/14/202 | $86,000 | – | 220,704 | +100.0% | 0.00% | – | |
Exit | OWLET INCcall | $0 | – | -220,704 | -100.0% | -0.00% | – | |
AZN | Exit | ASTRAZENECA PLCcall | $0 | – | -5,200 | -100.0% | -0.00% | – |
PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -177,113 | -100.0% | -0.01% | – |
MAPSW | Exit | WM TECHNOLOGY INCcall | $0 | – | -150,200 | -100.0% | -0.01% | – |
KZR | Exit | KEZAR LIFE SCIENCES INCcall | $0 | – | -113,400 | -100.0% | -0.01% | – |
SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -794,675 | -100.0% | -0.02% | – |
RGEN | Exit | REPLIGEN CORP | $0 | – | -14,724 | -100.0% | -0.05% | – |
Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -135,000 | -100.0% | -0.06% | – | |
Exit | APTOSE BIOSCIENCES INC | $0 | – | -2,594,348 | -100.0% | -0.06% | – | |
NBTX | Exit | NANOBIOTIX SAsponsored ads | $0 | – | -500,000 | -100.0% | -0.06% | – |
Exit | OWLET INC | $0 | – | -1,200,000 | -100.0% | -0.07% | – | |
EVH | Exit | EVOLENT HEALTH INCcall | $0 | – | -250,000 | -100.0% | -0.08% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -13,560 | -100.0% | -0.09% | – |
CNVY | Exit | CONVEY HLDG PARENT INC | $0 | – | -1,000,000 | -100.0% | -0.09% | – |
KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -3,438,998 | -100.0% | -0.10% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -45,580 | -100.0% | -0.10% | – |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,150,000 | -100.0% | -0.11% | – |
MAPS | Exit | WM TECHNOLOGY INC | $0 | – | -700,400 | -100.0% | -0.11% | – |
Exit | DICE THERAPEUTICS INC | $0 | – | -440,000 | -100.0% | -0.16% | – | |
FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -2,769,383 | -100.0% | -0.19% | – |
Exit | HUMACYTE INC | $0 | – | -1,500,000 | -100.0% | -0.19% | – | |
VRCA | Exit | VERRICA PHARMACEUTICALS INC | $0 | – | -1,479,733 | -100.0% | -0.20% | – |
CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -7,520,600 | -100.0% | -0.24% | – |
OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -807,792 | -100.0% | -0.24% | – |
MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -17,264,764 | -100.0% | -0.46% | – |
CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -612,700 | -100.0% | -0.75% | – |
PGNY | Exit | PROGYNY INC | $0 | – | -1,270,045 | -100.0% | -0.78% | – |
DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -2,183,143 | -100.0% | -0.82% | – |
ANTM | Exit | ANTHEM INC | $0 | – | -207,100 | -100.0% | -0.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOGEN INC | 42 | Q3 2023 | 5.0% |
VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
AMGEN INC | 40 | Q3 2023 | 5.5% |
INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
Passage BIO, Inc. | June 29, 2023 | 8,034,000 | 14.7% |
Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-27 |
SC 13D/A | 2024-03-22 |
SC 13D/A | 2024-03-21 |
SC 13D/A | 2024-03-08 |
144 | 2024-03-04 |
SC 13D/A | 2024-02-21 |
13F-HR | 2024-02-14 |
4 | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.